| Dr Michael S Skaar Jr, PHARMD | |
|
321 Main St, Winooski, VT 05404-1380 | |
| (802) 655-2444 | |
| Not Available |
| Full Name | Dr Michael S Skaar Jr |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 321 Main St, Winooski, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104339092 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 033.0134089 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael S Skaar Jr, PHARMD 109 Intervale Ave, Burlington, VT 05401-4204 Ph: (802) 495-6715 | Dr Michael S Skaar Jr, PHARMD 321 Main St, Winooski, VT 05404-1380 Ph: (802) 655-2444 |
News Archive
The use of combined treatments for severe acute pancreatitis is safe and effective in managing the disease, resulting in shorter hospitalizations and fewer radiological procedures than standard therapy, according to a study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute. In a related study, doctors found that patients with infected pancreatic necrosis were able to avoid surgery through primary conservative treatment, which is in-patient medical treatment.
Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, gained international validation of the cutting-edge science behind its lead oncology product, Rexin-G, when scientists around the world rediscovered the Cyclin G1 gene to be a major locus of cancer pathogenesis and disease progression, and thus a prime target for anti-cancer therapies.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has held its second meeting with the Australian Therapeutic Goods Administration ("TGA") to discuss milestones for approval of PV-10 for treatment of metastatic melanoma. The TGA is the part of the Australian Government's Department of Health and Ageing responsible for the assessment, approval and monitoring of therapeutic goods available in Australia. The initial meeting with the TGA was held in October 2008.
Alere Inc. is pleased to announce the results of a study, presented today at the 20th FIGO World Congress of Obstetrics and Gynecology, which demonstrate that a simple blood test measuring placental growth factor (PlGF) can help to quantify risk in women when pre-eclampsia is first suspected.
› Verified 5 days ago
Mr. Riyaz Merali, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 321 Main St, Suite B, Winooski, VT 05404 Phone: 802-655-3544 | |
John Joy, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 321 Main St, Winooski, VT 05404 Phone: 802-655-5473 | |
Lara Elizabeth Dusek, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13 E Spring St Apt A, Winooski, VT 05404 Phone: 703-731-6104 | |
Chelsea Dawn Leblanc, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 321 Main St, Winooski, VT 05404 Phone: 802-655-2444 | |
Allison Pratt, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 321 Main St, Winooski, VT 05404 Phone: 802-655-2444 | |
Lyndsi Branon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 321 Main St, Winooski, VT 05404 Phone: 802-655-2444 |